Letter: safety of proton pump inhibitors during pregnancy
- PMID: 32886386
- DOI: 10.1111/apt.15914
Letter: safety of proton pump inhibitors during pregnancy
Comment in
-
Letter: safety of proton pump inhibitors during pregnancy-authors' reply.Aliment Pharmacol Ther. 2020 Aug;52(4):740-741. doi: 10.1111/apt.15947. Aliment Pharmacol Ther. 2020. PMID: 32886407 No abstract available.
Comment on
-
Systematic review with meta-analysis: the risks of proton pump inhibitors during pregnancy.Aliment Pharmacol Ther. 2020 Feb;51(4):410-420. doi: 10.1111/apt.15610. Epub 2020 Jan 7. Aliment Pharmacol Ther. 2020. PMID: 31909512
References
REFERENCES
-
- Li CM, Zhernakova A, Engstrand L, Wijmenga C, Brusselaers N. Systematic review with meta-analysis: the risks of proton pump inhibitors during pregnancy. Aliment Pharmacol Ther. 2020;51:410-420.
-
- Dolk H, Loane M, Garne E. The prevalence of congenital anomalies in Europe. Adv Exp Med Biol. 2010;686:349-364.
-
- Yu X, Nassar N, Mastroiacovo P, et al. Hypospadias prevalence and trends in international birth defect surveillance systems, 1980-2010. Eur Urol. 2019;76:482-490.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources